The Global Burden of Rheumatic Heart Disease
>30 million people*
A SIGNIFICANT PROPORTION OF PATIENTS WITH RHD
WILL NEED HEART VALVE SURGERY
*World Health Organisation
Explaining the Problem
Rheumatic Heart Disease (RHD) is a most under-appreciated deadly disease affecting 70-100 million people worldwide. In 2017 the WHO declared it to be a global health threat. RHD is a preventable condition triggered by streptococcal bacteria. This bacterium is responsible for a common throat infection known as ‘Strep Throat’. When left untreated, a patient’s immune system can turn against his own heart while fighting the infection. This leads to an acute inflammation of the heart and the heart valves accompanied by fever (Acute Rheumatic Fever).
Rheumatic Fever primarily affects poor, young people
between the age of 5 and 15.
It is often followed by chronic RHD that irreversibly damages the patient’s heart valves. Once patients become symptomatic, open heart surgery is currently the only life-saving treatment. In order to provide heart valve surgery to all patients in need, Low- to Middle-Income Countries would require >5,000 new heart centers.
Without sufficient access to cardiac surgery,
millions of RHD patients are doomed to die prematurely.
While Heart Centers capable of open heart surgery are a scarcity in most regions with a high prevalence of RHD, the number of Regional Hospitals with good general surgical skills has been continually increasing over recent decades. The potential role of such hospitals in expanding cardiac care is widely accepted.
SAT solutions eliminate the requirement for open-heart surgery, reducing the need for sophisticated infrastructure and specialist skills. We greatly expand the capacity of existing cardiac facilities and enable the utilization of general surgical operating facilities for heart valve procedures.
SAT TECHNOLOGY OFFERS COST EFFECTIVE, AND MINIMALLY INVASIVE TRANSCATHETER HEART THERAPIES – allowing patients to undergo treatment where there is currently no option
SAT’s heart valves are created for young patients in whom conventional heart valve prostheses often degenerate rapidly. Specifically, SAT’s valves are designed for longer durability and more secure anchorage. These properties are also beneficial in older patients requiring heart valve surgery for age or lifestyle reasons.